Single nuclei transcriptomics of muscle reveals intra-muscular cell dynamics linked to dystrophin loss and rescue
Open Access
- 19 September 2022
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 5 (1) , 1-14
Abstract
In Duchenne muscular dystrophy, dystrophin loss leads to chronic muscle damage, dysregulation of repair, fibro-fatty replacement, and weakness. We develop methodology to efficiently isolate individual nuclei from minute quantities of frozen skeletal muscle, allowing single nuclei sequencing of irreplaceable archival samples and from very small samples. We apply this method to identify cell and gene expression dynamics within human DMD andmdxmouse muscle, characterizing effects of dystrophin rescue by exon skipping therapy at single nuclei resolution.DMDexon 23 skipping events are directly observed and increased in myonuclei from treated mice. We describe partial rescue of type IIa and IIx myofibers, expansion of an MDSC-like myeloid population, recovery of repair/remodeling M2-macrophage, and repression of inflammatory POSTN1 + fibroblasts in response to exon skipping and partial dystrophin restoration. Use of this method enables exploration of cellular and transcriptomic mechanisms of dystrophin loss and repair within an intact muscle environment. Our initial findings will scaffold our future work to more directly examine muscular dystrophies and putative recovery pathways.Keywords
All Related Versions
Funding Information
- Muscular Dystrophy Association (MDA603685)
- Parent Project Muscular Dystrophy
- U.S. Department of Health & Human Services | National Institutes of Health (HG002536, T32AR065972)
- UC | UCLA | Center for Duchenne Muscular Dystrophy, University of California, Los Angeles
- U.S. Department of Health & Human Services | National Institutes of Health
- CDMD Seed Grant CDMD Appel Seed Grant California Center for Rare Diseases
This publication has 74 references indexed in Scilit:
- Anti-Dystrophin T Cell Responses in Duchenne Muscular Dystrophy: Prevalence and a Glucocorticoid Treatment EffectHuman Gene Therapy, 2013
- Satellite Cells and the Muscle Stem Cell NichePhysiological Reviews, 2013
- High-Resolution Transcriptome of Human MacrophagesPLOS ONE, 2012
- Upregulation of chemokines and their receptors in duchenne muscular dystrophy: potential for attenuation of myofiber necrosisMuscle & Nerve, 2012
- The Paradox of Muscle Hypertrophy in Muscular DystrophyPhysical Medicine and Rehabilitation Clinics of North America, 2012
- Telethonin-deficiency initially presenting as a congenital muscular dystrophyNeuromuscular Disorders, 2011
- Dystrophin Immunity in Duchenne's Muscular DystrophyNew England Journal of Medicine, 2010
- Depletion of zebrafish Tcap leads to muscular dystrophy via disrupting sarcomere–membrane interaction, not sarcomere assemblyHuman Molecular Genetics, 2009
- Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-βJournal of Clinical Investigation, 2009
- Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in miceDevelopmental Dynamics, 2007